OICR News / Tag

FACIT

Browse news tagged FACIT.

Browse all news

Filters

Discover the latest news and insightsDiscover the latest news and insights

All Collaboration Commercialization Talent Technology

All Video Article

Tagged stories

Commercialization

FACIT pitch competition empowers Ontario’s oncology entrepreneurs

Falcons’ Fortunes gives Ontario innovators the chance to showcase their innovations each year for a chance at the $100,000 Ernsting Entrepreneurship Award, with much of FACIT’s support happening behind the scenes. For Dr. Saumik Biswas…

ArticleAug 08, 2022

Commercialization

Two OICR innovations bolstered by investments from FACIT

Investments will support high-profile work led by Dr. Rima Al-awar and Dr. Lincoln Stein. Groundbreaking projects in OICR’s Drug Discovery and Adaptive Oncology research themes are receiving support to advance made-in-Ontario innovations thanks to investments…

ArticleApr 28, 2022

Commercialization

FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund

Replica Analytics & Sunnybrook’s Czarnota Lab receive key seed funding to de-risk Ontario intellectual property TORONTO, ON (June 23, 2020) – FACIT, a commercialization venture firm, announced the newest recipients of Ontario First seed capital…

ArticleJun 23, 2020

Commercialization

FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)

Award acknowledges FACIT’s commercialization impact in growing Ontario’s life sciences industry FACIT, a commercialization venture firm, has been nationally recognized with CVCA’s 2020 Venture Capital Regional Impact Award for Ontario. The CVCA helps to set…

ArticleJun 09, 2020

Commercialization

FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research

TORONTO, ON (November 6, 2019) – FACIT, a commercialization venture venture firm, reported on the expansion of its Executive-in-Residence program and new strategic initiatives. Ontario is home to world-leading cancer research connected through the collaboration model…

ArticleNov 06, 2019

Commercialization

FACIT and University of Toronto launch precision medicine company: Cellular Analytics

Next generation liquid biopsy platform to revolutionize companion diagnostics TORONTO, ON (October 30, 2019) – FACIT, a commercialization venture group, together with the University of Toronto (“U of T”), announced the creation of Ontario-based Cellular…

ArticleOct 30, 2019

← Previous Next stories →

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.